Biodexa Pharmaceticals Stock Price on October 21, 2024
| BDRX Stock | 4.98 0.41 8.97% |
Below is the normalized historical share price chart for Biodexa Pharmaceticals extending back to December 07, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Biodexa Pharmaceticals stands at 4.98, as last reported on the 26th of November, with the highest price reaching 5.11 and the lowest price hitting 4.22 during the day.
If you're considering investing in Biodexa Stock, it is important to understand the factors that can impact its price. Biodexa Pharmaceticals secures Sharpe Ratio (or Efficiency) of -0.0866, which signifies that the company had a -0.0866% return per unit of risk over the last 3 months. Biodexa Pharmaceticals exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Biodexa Pharmaceticals' Standard Deviation of 11.7, risk adjusted performance of (0.07), and Mean Deviation of 6.55 to double-check the risk estimate we provide.
At this time, Biodexa Pharmaceticals' Common Stock is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 33.2 K in 2024, whereas Total Stockholder Equity is likely to drop slightly above 4.4 M in 2024. . Price Earnings To Growth Ratio is likely to rise to 0 in 2024, whereas Price To Sales Ratio is likely to drop 4.15 in 2024. Biodexa Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 7th of December 2015 | 200 Day MA 19.8139 | 50 Day MA 6.1299 | Beta 1.438 |
Biodexa |
Sharpe Ratio = -0.0866
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BDRX |
Estimated Market Risk
| 12.03 actual daily | 96 96% of assets are less volatile |
Expected Return
| -1.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Biodexa Pharmaceticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biodexa Pharmaceticals by adding Biodexa Pharmaceticals to a well-diversified portfolio.
Price Book 0.2417 | Enterprise Value Ebitda 0.0308 | Price Sales 31.9812 | Shares Float 2.4 B | Wall Street Target Price 156.425 |
Biodexa Pharmaceticals Main Headline on 21st of October 2024
Levi Korsinsky Announces an Investigation on Behalf of Biode... by accesswire.com
NEW YORK, NY ACCESSWIRE October 21, 2024 Levi Korsinsky notifies investors that it has commenced an investigation of Biodexa Pharmaceuticals Plc c
Biodexa Pharmaceticals Valuation on October 21, 2024
It is possible to determine the worth of Biodexa Pharmaceticals on a given historical date. On October 21, 2024 Biodexa was worth 5.58 at the beginning of the trading date compared to the closed value of 5.98. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Biodexa Pharmaceticals stock. Still, in general, we apply an absolute valuation method to find Biodexa Pharmaceticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Biodexa Pharmaceticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Biodexa Pharmaceticals' related companies.
| Open | High | Low | Close | Volume | |
| 5.80 | 6.40 | 5.55 | 5.70 | 162,118 | |
10/21/2024 | 5.58 | 6.25 | 5.56 | 5.98 | 71,002 |
| 5.85 | 6.43 | 5.61 | 6.24 | 82,342 |
| Backtest Biodexa Pharmaceticals | | | Biodexa Pharmaceticals History | | | Biodexa Pharmaceticals Valuation | Previous | Next |
Biodexa Pharmaceticals Trading Date Momentum on October 21, 2024
| On October 22 2024 Biodexa Pharmaceticals was traded for 6.24 at the closing time. The top price for the day was 6.43 and the lowest listed price was 5.61 . The trading volume for the day was 82.3 K. The trading history from October 22, 2024 was a factor to the next trading day price jump. The overall trading delta against the next closing price was 4.35% . The overall trading delta against the current closing price is 3.68% . |
Biodexa Pharmaceticals Fundamentals Correlations and Trends
By evaluating Biodexa Pharmaceticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Biodexa Pharmaceticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Biodexa financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Biodexa Pharmaceticals Stock history
Biodexa Pharmaceticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Biodexa is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Biodexa Pharmaceticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Biodexa Pharmaceticals stock prices may prove useful in developing a viable investing in Biodexa Pharmaceticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 31.6 K | 33.2 K | |
| Net Loss | -6.3 M | -6.6 M |
Biodexa Pharmaceticals Quarterly Net Working Capital |
|
Biodexa Pharmaceticals Stock Technical Analysis
Biodexa Pharmaceticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Biodexa Pharmaceticals Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
Biodexa Pharmaceticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Biodexa Pharmaceticals November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Biodexa Pharmaceticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Biodexa Pharmaceticals shares will generate the highest return on investment. By undertsting and applying Biodexa Pharmaceticals stock market strength indicators, traders can identify Biodexa Pharmaceticals entry and exit signals to maximize returns
Biodexa Pharmaceticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Biodexa Pharmaceticals' price direction in advance. Along with the technical and fundamental analysis of Biodexa Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Biodexa to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (1.61) | |||
| Total Risk Alpha | (3.08) | |||
| Treynor Ratio | (0.41) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Biodexa Stock Analysis
When running Biodexa Pharmaceticals' price analysis, check to measure Biodexa Pharmaceticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodexa Pharmaceticals is operating at the current time. Most of Biodexa Pharmaceticals' value examination focuses on studying past and present price action to predict the probability of Biodexa Pharmaceticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodexa Pharmaceticals' price. Additionally, you may evaluate how the addition of Biodexa Pharmaceticals to your portfolios can decrease your overall portfolio volatility.